ENvue Medical, Inc. (FEED) — Financial statements
Income statement, balance sheet, and cash flow for ENvue Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3↓0.2% | 3↑12.0% | 2↑203.6% | 0.75↓55.6% | 2 | |
| Cost of Revenue | 2↑128.6% | 1↑40.8% | 0.75↑27.5% | 0.59↓36.8% | 0.93 | |
| Gross Profit | 0.15↓89.9% | 2↓1.9% | 2↑820.4% | 0.17↓78.3% | 0.77 | |
| Operating Expenses | ||||||
| R&D Expenses | 2↑93.8% | 0.91↑391.4% | 0.19↓34.6% | 0.28↓3.4% | 0.29 | |
| General & Administrative Expenses | 8↑120.5% | 3↓11.8% | 4↓0.2% | 4↓22.3% | 5 | |
| Selling & Marketing Expenses | 2↑246.3% | 0.72↓16.7% | 0.86↓10.5% | 0.97↓12.4% | 1 | |
| SG&A Expenses | 10↑142.2% | 4↓12.7% | 5↓2.2% | 5↓20.5% | 6 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 12↑133.6% | 5↑2.4% | 5↓4.0% | 5↓19.7% | 6 | |
| Total Costs & Expenses | 14↑132.7% | 6↑7.4% | 6↓0.8% | 6↓21.9% | 7 | |
| Operating Results | ||||||
| Operating Income | -12↓227.6% | -4↓4.2% | -3↑31.4% | -5↑11.8% | -6 | |
| Depreciation & Amortization | 0.90↑89600.0% | 0.00↑0.0% | 0.00↑0.0% | 0.00↓50.0% | 0.00 | |
| EBITDA | -11↓194.1% | -4↓7.3% | -3↑36.5% | -5↑62.0% | -14 | |
| EBIT | -12↓218.4% | -4↓7.3% | -3↑36.5% | -5↑62.0% | -14 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↑100.0% | -0.14↑45.1% | -0.25↑29.1% | -0.35 | 0.00 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00↓100.0% | 0.14↓45.1% | 0.25↓29.1% | 0.35 | 0.00 | |
| Non-Operating Income | 0.00↓100.0% | 0.10↓6.3% | 0.11↓72.3% | 0.40↓95.3% | 9 | |
| Other Income / Expenses | -7↓6397.1% | -0.10↑57.7% | -0.25↑38.7% | -0.40↑95.3% | -9 | |
| Income Before Tax | -18↓401.7% | -4↓0.1% | -4↑32.0% | -5↑62.0% | -14 | |
| Income Tax Expense | -0.31↓1715.8% | 0.02↓34.5% | 0.03↓17.1% | 0.04↑9.4% | 0.03 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -18↓390.8% | -4↑0.2% | -4↑31.9% | -5↑61.9% | -14 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -18↓390.8% | -4↑0.2% | -4↑31.9% | -5↑61.9% | -14 | |
| Bottom-Line Net Income | -17↓352.8% | -4↑0.2% | -4↑31.9% | -5↑61.9% | -14 | |
| EPS (Basic) | -19.54↑85.8% | -137.30↑41.1% | -233.25↑44.7% | -422.14↑66.2% | -1,248.68 | |
| EPS (Diluted) | -19.54↑85.8% | -137.30↑41.1% | -233.25↑44.7% | -422.14↑66.2% | -1,248.68 | |
| Weighted Average Shares | 0.86↑3081.3% | 0.03↑69.6% | 0.02↑23.3% | 0.01↑12.8% | 0.01 | |
| Weighted Average Diluted Shares | 0.86↑3081.3% | 0.03↑69.6% | 0.02↑23.3% | 0.01↑12.8% | 0.01 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.